Morgan Stanley has revised its price targets for major Chinese equity indices, anticipating moderate growth driven by improved earnings and a stronger yuan against the dollar. The new targets for 2Q 2027 include 28,400 for the Hang Seng Index, 91 for the MSCI China Index, 9,900 for the HSCEI, and 5,400 for the CSI-300, suggesting potential upsides of 8%, 12%, 11%, and 11%, respectively. The investment bank's strategists, led by Laura Wang, highlight the significant opportunities within China's equity market, particularly in technology and innovation sectors, which align with the country's 15th Five-Year Plan. They also note that China's competitive supply chain positions it favorably in the high-end power and green tech sectors, especially amid global energy demands heightened by geopolitical tensions. Furthermore, the upcoming meeting between U.S. President Donald Trump and Chinese President Xi Jinping may lead to trade relaxations and discussions on critical issues such as fentanyl and climate change, potentially enhancing investor interest in Chinese markets.